Naltrexone (International)
Note: In some countries, this medicine may only be approved for veterinary use.
In the US, Naltrexone (naltrexone systemic) is a member of the following drug classes: antidotes, drugs used in alcohol dependence and is used to treat Alcohol Use Disorder, Fibromyalgia, Opioid Use Disorder, Smoking Cessation and Trichotillomania.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N07BB04
CAS registry number (Chemical Abstracts Service)
0016590-41-3
Chemical Formula
C20-H23-N-O4
Molecular Weight
341
Therapeutic Categories
Antidote
Opioid receptor antagonist
Chemical Name
Morphinan-6-one, 17-(cyclopropylmetyl)-4,5-epoxy-3,14-dihydroxy-, (5α)-
Foreign Names
- Naltrexonum (Latin)
- Naltrexon (German)
- Naltrexone (French)
- Naltrexona (Spanish)
Generic Names
- Naltrexone (OS: DCF, DCIT, USAN, BAN)
- UM 792 (IS)
- Naltrexone Hydrochloride (OS: BANM)
- EN-1639 A (DuPont Merck) (IS)
- Naltrexone Hydrochloride (PH: BP 2018, USP 41)
- Naltrexone hydrochloride (PH: Ph. Eur. 9)
- Naltrexoni hydrochloridum (PH: Ph. Eur. 9)
Brand Names
- Abernil
Medochemie, Cyprus - Adepend
Norameda, Lithuania; Orpha-Devel, Slovenia; Providens, Croatia (Hrvatska); UAB “STADA-Nizhpharm-Baltija”, Estonia - Mysimba [+ Bupropion]
Orexigen, Lithuania; Orexigen, Latvia; Orexigen Therapeutics Ireland, Slovenia - Mysimba 8 mg/90 mg retard [+ Bupropion]
Orexigen, Hungary - Nalerona
ABL Pharma, Peru; Laboratorios Andromaco, Chile - Naltrexone
Haupt Pharma Wolfratshausen, Serbia - Naltrexone Accord
Accord Healthcare, France; Accord, Lithuania - Naltrexone Accord Healthcare
Accord Healthcare, Italy - Naltrexone AOP
AOP Orphan, Lithuania - Naltrexone AOP 50 mg
AOP, Hungary - Naltrexone Hydrochloride
Accord Healthcare, Cyprus - Naltrexone Mylan
Mylan, Cyprus - Naprosyne EC-500
CSL Behring, Luxembourg - Uninaltrex
União Química, Brazil - Vivitrol
Alkermes, Russian Federation; Alkermes, United States - Abernil
Medochemie, Malta; Medochemie Vietnam, Vietnam - Addtrex
Rusan Pharma Ltd., Georgia - Adepend
AOP Orphan, Bulgaria; Orpha Devel, Czech Republic; Orpha-Devel, Denmark; Orpha-Devel, Poland - Adepend 50mg
AOP Orphan Pharmaceuticals, United Kingdom; Desitin, Germany; Orpha, Hungary - Anarcol
October Pharma, Egypt - Antaxone
Zambon, Georgia; Zambon, Italy - Apo-Naltrexone
Apotex, Australia; Apotex, Canada - Contrave [+ Bupropion]
Orexigen, United States - Dependex 50 mg
Amomed Pharma, Austria - Destoxican
Pentafarma, Portugal - Embeda [+ Morphine]
Alpharma, United States - Ethylex
Dem Ilac, Turkey - Ethylex 50 mg
Orpha-Devel, Austria - Mysimba [+ Bupropion]
CentralPharma, Estonia; Consilient, Ireland; Consilient Health, United Kingdom; Navamedic, Denmark; Navamedic, Finland; Navamedic, Sweden; Orexigen, Czech Republic; Orexigen, Norway; Orexigen Therapeutics, Romania; Orexigen Therapeutics Ireland Ltd, Greece; Orexigen Therapeutics Ireland, Portugal; Rovi, Spain; Valeant, Slovakia - Nalcotrex
Ariston, Argentina - Nalerona
Silesia, Paraguay - Nalorex
Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb Pharmaceutical, United Kingdom; Central Procurement & Supplies Unit, Malta; L. Molteni & C. dei F.lli Alitti Società di Esercizio, Italy - Nalorex 50mg
Bristol-Myers Squibb, Luxembourg - Naltraccord
Teva, New Zealand - Naltrax
Navana, Bangladesh - Naltrexin
Yungjin, South Korea - Naltrexin 50mg
OrPha Swiss, Switzerland - Naltrexon Abcur
Molteni Farmaceutici, Sweden - Naltrexon Accord
Accord Healthcare, Denmark - Naltrexon AOP
AOP Orphan Pharmaceuticals, Denmark - Naltrexon HCl aop
Desitin, Germany; Orphan Europe, Netherlands - Naltrexon HCl Sandoz
Sandoz, Netherlands - Naltrexon Hydrochloride Accord
Accord Healthcare, Netherlands - Naltrexon Vitaflo
AOP Orphan Pharmaceuticals, Finland; AOP Orphan Pharmaceuticals, Sweden - Naltrexona Accord
Accord, Spain; Accord, Portugal - Naltrexona Destoxican
Pentafarma, Portugal - Naltrexona Torrex
Chiesi Pharmaceuticals, Romania - Naltrexone Accord
Accord Healthcare, Belgium; Accord Healthcare, Bulgaria; Accord Healthcare, Estonia; Accord Healthcare, Latvia; Accord Healthcare, Sweden - Naltrexone AOP
AOP, Latvia; Providens, Croatia (Hrvatska) - Naltrexone GH
Generic Health, Australia - Naltrexone HCL L.Molteni
L. Molteni, Hong Kong - Naltrexone Hydrochloride
Accord Healthcare, United Kingdom; Accord Healthcare, Malta; Accord Healthcare, United States; Apotex, United States; Barr, United States; Elite, United States; Mallinckrodt, United States; Sun Pharma, United States - Naltrexone Hydrochloride Accord
Accord Healthcare, Poland - Naltrexone Hydrochloride Sterinova
Sterinova, Canada - Naltrexone Mylan
Mylan, France - Naltrexone POA Pharma
POA, Norway; POA Pharma, Denmark; POA Pharma, Sweden - Naltrexon-HCI neuraxpharm
neuraxpharm Arzneimittel, Germany - Naltrexonhydrochlorid Accord
Accord Healthcare, Germany - Naltrexonhydrochloride PCH
Pharmachemie, Netherlands - Narcoral
Sirton, China; Sirton Medicare, Italy - Nemexin
Bristol-Myers Squibb, Germany - Nuo Xin Sheng
Sihuan Pharmaceutical Factory, China - Nutrexon
Nufarindo, Indonesia - Phaltrexia
Pharos, Indonesia - Prodetoxon
ZAO, Georgia - Regental
Teva, Uruguay - Revez
S.Chobet, Argentina - Revia
Bristol-Myers Squibb, France; Bristol-Myers Squibb, New Zealand; Cristália, Brazil; Du Pont, Kuwait; Gervasi, Spain; Jeil, South Korea; Tchero, Egypt; Torrex Chiesi, Lithuania - ReVia
Bristol-Myers Squibb, Australia; Teva Canada, Canada - Revia 50 mg
Chiesi Pharmaceuticals, Austria; Eurim-Pharm, Austria - Trexonil [veterinary use]
Wildlife Laboratories, United States; Wildlife Pharma, South Africa
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.